The genetic profile of “APL-like” NPM1m AML in our cohort shows that, indeed, it has a much higher frequency of IDH1/2 or TET2 mutations compared to the rest of the NPM1m AML cases [18,37,38,39]. This evidence concerns the gene TET2 and acute promyelocytic leukemia.